✦ LIBER ✦

Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase–producing Klebsiella pneumoniae and Escherichia coli

✍ Scribed by Yeon-Joon Park; Jin Kyung Yu; Kang Gyun Park; Yong Gyu Park; Seongok Lee; Soo-Young Kim; Seok Hoon Jeong

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic evolution and clinical impact in

✍ Yong Chong; Yoshikiyo Ito; Tomohiko Kamimura 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Prevalence of extended-spectrum β-lactam

✍ M. Mushfequr Rahman; J. Ashraful Haq; M. Akram Hossain; Rosy Sultana; Faridul Is 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Clinical manifestations and prognostic f

✍ Shu-Shen Wang; Nan-Yao Lee; Po-Ren Hsueh; Wei-Han Huang; Ko-Chung Tsui; Hsin-Chu 📂 Article 📅 2011 🏛 Scientific Communications 🌐 English ⚖ 244 KB

Pharmacodynamic profiling of imipenem, m

✍ Carlos R.V. Kiffer; Joseph L. Kuti; Kathryn J. Eagye; Caio Mendes; David P. Nico 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Extended-spectrum β-lactamase (ESBL) CTX

✍ R. Markovska; I. Schneider; E. Keuleyan; A. Bauernfeind 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

In Vitro Activity of Cefepime, Imipenem,

✍ Raymond Cha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB